For Investors

• Analyst Coverage
• Annual Reports
• Calendar
• Contact Investor Relations
• Financial Reports
• Frequently Asked Questions
• Management and Investor Relations
• Media Coverage
• News Releases
• Presentations
• Request Documents
• SEDAR Filings
• Stock Quote
• Webcasts
• Why Invest?

News Releases ::

• Isotechnika announces first sale of commercial supply of voclosporin
  More...October 6, 2008
  
• Isotechnika selected to present at international transplantation conference
  More...September 24, 2008
  
• Isotechnika hires advisors to advance strategic alternatives
  More...August 27, 2008
  

Media Coverage ::

• Isotechnika reports positive Phase 2b trial of voclosporin kidney-transplant drug
  More...May 27, 2008
• Voclosporin reduces plaques, has fewer side effects than cyclosporine
  More...May 5, 2008
• Voclosporin (ISA247) psoriasis trial shows impressive results
  More...April 18, 2008

Contact Investor Relations

Isotechnika Inc.
5120 - 75th Street
Edmonton, Alberta
T6E 6W2
Telephone: 780-487-1600
Fax: 780-484-4105
E-mail: Investor Relations

Isotechnika Contact Us